Allianz Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-32,700
| Closed | -$606K | – | 2272 |
|
|
2023
Q3 | $606K | Buy |
+32,700
| New | +$370K | ﹤0.01% | 1861 |
|
|
2020
Q4 | – | Sell |
-10,441
| Closed | -$433K | – | 1974 |
|
|
2020
Q3 | $433K | Buy |
10,441
+5,516
| +112% | +$253K | ﹤0.01% | 1635 |
|
|
2020
Q2 | $236K | Sell |
4,925
-2,799
| -36% | -$216K | ﹤0.01% | 2254 |
|
|
2020
Q1 | $486K | Sell |
7,724
-7,441
| -49% | -$669K | ﹤0.01% | 2070 |
|
|
2019
Q4 | $1.88M | Buy |
15,165
+525
| +4% | +$47K | ﹤0.01% | 1900 |
|
|
2019
Q3 | $966K | Buy |
14,640
+9
| +0.1% | +$604 | ﹤0.01% | 2143 |
|
|
2019
Q2 | $1.16M | Buy |
14,631
+3,240
| +28% | +$290K | ﹤0.01% | 2087 |
|
|
2019
Q1 | $1.27M | Buy |
11,391
+2,973
| +35% | +$325K | ﹤0.01% | 2009 |
|
|
2018
Q4 | $829K | Sell |
8,418
-751
| -8% | -$77.8K | ﹤0.01% | 2099 |
|
|
2018
Q3 | $1.16M | Buy |
9,169
+1,369
| +18% | +$145K | ﹤0.01% | 2170 |
|
|
2018
Q2 | $655K | Hold |
7,800
| – | – | ﹤0.01% | 2332 |
|
|
2018
Q1 | $480K | Hold |
7,800
| – | – | ﹤0.01% | 2392 |
|
|
2017
Q4 | $456K | Buy |
7,800
+2,800
| +56% | +$177K | ﹤0.01% | 2435 |
|
|
2017
Q3 | $290K | Sell |
5,000
-2,772
| -36% | -$299K | ﹤0.01% | 2531 |
|
|
2017
Q2 | $953K | Sell |
7,772
-100
| -1% | -$11.6K | ﹤0.01% | 2237 |
|
|
2017
Q1 | $889K | Buy |
7,872
+277
| +4% | +$32.3K | ﹤0.01% | 2272 |
|
|
2016
Q4 | $825K | Sell |
7,595
-2,164
| -22% | -$258K | ﹤0.01% | 2263 |
|
|
2016
Q3 | $1.57M | Buy |
9,759
+1,294
| +15% | +$204K | ﹤0.01% | 2078 |
|
|
2016
Q2 | $1.21M | Sell |
8,465
-3,730
| -31% | -$544K | ﹤0.01% | 2116 |
|
|
2016
Q1 | $1.57M | Buy |
12,195
+150
| +1% | +$17.7K | ﹤0.01% | 1917 |
|
|
2015
Q4 | $1.8M | Sell |
12,045
-15,815
| -57% | -$2.68M | ﹤0.01% | 1745 |
|
|
2015
Q3 | $4.62M | Buy |
27,860
+1,060
| +4% | +$233K | 0.01% | 1313 |
|
|
2015
Q2 | $6.47M | Sell |
26,800
-16,055
| -37% | -$4.28M | 0.01% | 1290 |
|
|
2015
Q1 | $12.1M | Sell |
42,855
-30
| -0.1% | -$6.5K | 0.01% | 874 |
|
|
2014
Q4 | $6.69M | Buy |
42,885
+14,025
| +49% | +$2.59M | 0.01% | 1108 |
|
|
2014
Q3 | $6.83M | Buy |
28,860
+16,415
| +132% | +$4.19M | 0.01% | 970 |
|
|
2014
Q2 | $2.94M | Sell |
12,445
-3,255
| -21% | -$858K | ﹤0.01% | 1071 |
|
|
2014
Q1 | $5.18M | Buy |
+15,700
| New | +$5.3M | 0.01% | 947 |
|
Allianz Asset Management's ICPT Position: Q4 2023 in Review
Allianz Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 32,700 shares — an estimated $606K sold.
Allianz Asset Management first reported a position in ICPT in Q1 2014 and held it in 28 quarters. The position peaked at $12.1M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Allianz Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Allianz Asset Management sold 32,700 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $606K.
- Allianz Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 28 quarters.
- Allianz Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $12.1M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Allianz Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.